Funding · Company
NextPoint Therapeutics, Inc.
Cambridge, MABiotech & Pharma
NextPoint Therapeutics, Inc. of Cambridge, MA has disclosed $122M across 2 Form D offerings filed with the SEC between Dec 27, 2022 and Feb 14, 2024.
$122M
Total disclosed
2
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001959209Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →